InvestorsHub Logo
Followers 603
Posts 24107
Boards Moderated 3
Alias Born 12/06/2009

Re: None

Thursday, 03/09/2017 1:03:02 AM

Thursday, March 09, 2017 1:03:02 AM

Post# of 106839
Data from Part one of Phase 2/3 MYOCELL trials

So Since we know that DATA is the most important piece to this stock's valuation, let's take a look at the some of the data for our #1 LEAD PRODUCT CANDIDATE: MYOCELL. To really get an understanding about MYOCELL you need to look into it's history. It took me since early January to find all this stuff, but in my opinion the DATA looks GOOD!!!!!!!!!!!!! Some of this stuff is hard to understand, but with a little critical thinking, you can put the pieces together, and realize why my hypothesis; about an FDA ACCELERATED APPROVAL scenario, is possible for this stock, and MYOCELL becomes commercialized. Under the FDA's accelerated approval process.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129031133

Go USRM!